Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Free Cash Flow (2020 - 2021)

Design Therapeutics' Free Cash Flow history spans 2 years, with the latest figure at -$10.7 million for Q4 2021.

  • For Q4 2021, Free Cash Flow fell 272.74% year-over-year to -$10.7 million; the TTM value through Dec 2021 reached -$30.9 million, down 256.04%, while the annual FY2025 figure was -$54.6 million, 25.56% down from the prior year.
  • Free Cash Flow for Q4 2021 was -$10.7 million at Design Therapeutics, down from -$8.1 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$1.3 million in Q2 2020 and bottomed at -$10.7 million in Q4 2021.